BMO

Wells Fargo & Co (NYSE: WFC)'s first-quarter earnings miss on a narrowing net interest margin and slow loan growth left analysts with divided opinions as the smoke cleared Wednesday. Shares traded recently at $54.59, up 0.74 percent. "It was a 'blah' quarter," said Oppenheimer's Christopher...

Gap Inc (NYSE: GPS) on Thursday reported its February net sales fell 1.2 percent from a year ago to $918 million, while same-store sales fell 4 percent. In a report published Thursday evening, UBS analyst Roxanne Meyer commented on the company's results, noting sales were impacted by...

American Eagle Outfitters (NYSE: AEO) reported Q4 earnings Thursday and beat analyst estimates. The stock spiked upwards nearly 10 percent following the earnings announcement and recently traded at $16.22. Analysts weighed in on the results and while some found the company's performance...

BMO analyst Joel Jackson suggested Thursday that the troubled Uralkali Solikamsk-2 mine may already be lost, according to Bloomberg. The mine was recently shut down as it developed a sink hole.  According to Jackson, electricity and the air supply to the mine have now been turned off....

Shares of Regeneron Pharmaceuticals (NASDAQ: REGN) are down three percent following BMO analyst Jim Birchenough's note of customers cost preference of Roche's Avastin. Birchenough remarked that there has been “broad reconsideration” of use of “low-cost” Avastin over Regeneron's Eylea by patients....

Coach (NYSE: COH) shares have continued to decline Friday after a raft of analysts downgraded the company on a weak outlook. The luxury handbag retailer disclosed expectations at a meeting with analysts Thursday, predicting same-store sales to drop to the "mid-to-high" 20 percent...

Shares of Elizabeth Arden (NASDAQ: RDEN) have traded as high as 14.42 percent on a rumored unconfirmed takeover bid by Korean LG Household & Healthcare. On April 22, Reuters reported that LG household is considering a bid for Elizabeth Arden. Following the company's earnings report on May 12,...

BMO downgraded Bristol-Myers Squibb (NYSE: BMY) from Outperform to a Market Perform rating. Alex Arfaei said, "We were wrong to extrapolate the strong efficacy seen with Bristol's Nivo+Yervoy combo in melanoma to lung (NSCLC) and kidney (RCC) cancer." Arfaei later went on to say, "Although BMS...

Mylan, Inc. (NASDAQ: MYL) shares took a 3+% hit today after BMO analyst David Maris commented that the FDA warning letter may issue an import ban on Agila products. On September 9th, the FDA sent a warning letter to Mylan regarding the use of non-sterile gloves for aseptic processing in Agila's...

BMO is out with its report today on CSX (NYSE: CSX), maintaining Outperform. In its report, BMO writes, "Although we do not sense that investors' expectations were high coming into Q3/11, we anticipate a muted response to results. Valuation is attractive in light of strong medium-to-long-term...